Position in GTBP
as of Jun 30, 2026
· filed Sep 9, 2026
Position Value
$9,802
+$1,640 QoQ
Shares Held
800
0.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 57 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GTBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Integrated Wealth Concepts LLC holds $35,390,713 across 55 Biotechnology names. GTBP ranks #53 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
84,046 | $4,809,112 | |
| 2 | INVA |
Innoviva, Inc.
|
178,507 | $4,053,893 | |
| 3 | EXEL |
Exelixis, Inc.
|
58,636 | $3,190,384 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,917 | $2,939,151 | |
| 5 | DNLI |
Denali Therapeutics Inc.
|
102,241 | $2,629,638 | |
| 6 | INCY |
Incyte Corp
|
17,069 | $1,934,941 | |
| 7 | TLX |
Telix Pharmaceuticals Ltd
|
164,397 | $1,895,497 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,299 | $1,433,518 |
All Filings in GTBP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,802 | 20,006 | Shares | Sole | 2026-09-09 | |
| 2026-03-31 | $8,162 | 20,006 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,704 | 20,006 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||